Biotech Values

[alertmeipp]

I was expecting larger upfront given MNTA's technology position - but as discussed, the deal is structured in a way that MNTA gives up some upside but it offloads the expense and uncertainty in the first 2 picks.

Any idea what the expense would be like to push the first 2 to the market if they were the one u guessed?